Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600470 · ClinicalTrials.gov registry record · Phase 1
Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders
A Phase 1 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 1
- Development phase
- 858
- Enrollment target
NCT00600470: Completed Phase 1 study, sponsored by University of Pittsburgh.
NCT00600470 is a Phase 1 study that has completed, run by University of Pittsburgh. The registered enrollment target is 858 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1330% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00600470, a Phase 1 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 858 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of a doctor-office collaborative care approach in treating children with disruptive behavior problems in the pediatric primary care setting.
Interventions
- BEHAVIORAL Treatment as usual (TAU)
- BEHAVIORAL Doctor-office collaborative care (DOCC) management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 858 participants |
| Start Date | 2000-09 |
| Est. Completion | 2013-08 |
| Phase | Phase 1 |
What the finished NCT00600470 record still lists
NCT00600470 is an interventional study that assigns participants to a tested intervention. The registered 858 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1330% higher).
The record links to 0 conditions, and to 2 interventions - of which Treatment as usual (TAU) is the first listed.
NCT00600470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00600470 about?
NCT00600470 is a clinical study titled "Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders". This study will evaluate the effectiveness of a doctor-office collaborative care approach in treating children with disruptive behavior problems in the pediatric primary care setting.
What is the current status of trial NCT00600470?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 858 participants. The study started on 2000-09. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00600470?
The interventions under investigation include: Treatment as usual (TAU) (BEHAVIORAL), Doctor-office collaborative care (DOCC) management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00600470?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00600470's enrollment target sits among peer trials
858 12th of 2000 higher than 1,989 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
- NCT06161025 · 860 participants · Phase 2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- NCT06541574 · 860 participants · Phase 2
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia